Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BI-1622 | 2681392-19-6 | 99.0% | 508.53 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY150023100MG

Encompass_Preferred

BI-1622 is an orally active, potent, and highly selective HER2 (ERBB2) inhibitor, exhibiting an IC50 of 7 nM. It demonstrates more than 25-fold selectivity over EGFR. BI-1622 has shown high antitumor efficacy in vivo within xenograft mouse tumor models using engineered H2170 and PC9 cells, coupled with a favorable agent metabolism and pharmacokinetics profile.

  • Orally active.
  • Potent and highly selective HER2 (ERBB2) inhibitor (IC50 of 7 nM).
  • Exhibits >25-fold selectivity over EGFR.
  • High antitumor efficacy in vivo in xenograft mouse tumor models.
  • Favorable agent metabolism and pharmacokinetics profile.
  • Inhibits proliferation of HER2-dependent cell lines.
  • Good permeability and no PgP-mediated efflux liability.

Catalog No. 50-003-59453


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.